Search research articles
Contact Us
Filters
Showing results (171-180 of 201) with videos related to
Page
of 21
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 13, 2018
Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial
Sudeep Gupta, Amita Maheshwari, Pallavi Parab, et al.
European Urology
|
August 14, 2022
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors
George J Netto, Mahul B Amin, Daniel M Berney, et al.
European Urology
|
July 19, 2022
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch, Mahul B Amin, Daniel M Berney, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2024
Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled Trial
Vedang Murthy, Priyamvada Maitre, Ganesh Bakshi, et al.
JCO Global Oncology
|
July 9, 2026
Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western India
Kunal Jobanputra, Aditya Dhanawat, Gagan Prakash, et al.
European Urology
|
October 6, 2022
Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification
George J Netto, Mahul B Amin, Eva M Compérat, et al.
Brachytherapy
|
September 16, 2023
Reirradiation with advanced brachytherapy techniques in recurrent GYN cancers
Umesh Mahantshetty, Sheetal R Kashid, Gargee Mulye, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 20, 2024
Expression of L1 Cell Adhesion Molecule, a Nephronal Principal Cell Marker, in Nephrogenic Adenoma
Rahul Mannan, Xiaoming Wang, Somnath Mahapatra, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 27, 2024
Biomarker Expression and Clinical Outcomes in International Study of Chemoradiation and Magnetic Resonance Imaging-Based Image-Guided Brachytherapy for Locally Advanced Cervical Cancer: BIOEMBRACE
Supriya Chopra, Tjalling Bosse, Nanda Horeweg, et al.
Histopathology
|
May 21, 2022
WHO 2022 landscape of papillary and chromophobe renal cell carcinoma
João Lobo, Riuko Ohashi, Mahul B Amin, et al.
Page
of 21
Search research articles
Search
Showing results (171-180 of 201) with videos related to
Sort By:
Page
of 21
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 13, 2018
Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Concomitant Chemotherapy and Radiotherapy in Patients With Stage IB2, IIA, or IIB Squamous Cervical Cancer: A Randomized Controlled Trial
Sudeep Gupta, Amita Maheshwari, Pallavi Parab, et al.
European Urology
|
August 14, 2022
The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors
George J Netto, Mahul B Amin, Daniel M Berney, et al.
European Urology
|
July 19, 2022
The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch, Mahul B Amin, Daniel M Berney, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 1, 2024
Bladder Adjuvant Radiation Therapy (BART): Acute and Late Toxicity From a Phase III Multicenter Randomized Controlled Trial
Vedang Murthy, Priyamvada Maitre, Ganesh Bakshi, et al.
JCO Global Oncology
|
July 9, 2026
Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western India
Kunal Jobanputra, Aditya Dhanawat, Gagan Prakash, et al.
European Urology
|
October 6, 2022
Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification
George J Netto, Mahul B Amin, Eva M Compérat, et al.
Brachytherapy
|
September 16, 2023
Reirradiation with advanced brachytherapy techniques in recurrent GYN cancers
Umesh Mahantshetty, Sheetal R Kashid, Gargee Mulye, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 20, 2024
Expression of L1 Cell Adhesion Molecule, a Nephronal Principal Cell Marker, in Nephrogenic Adenoma
Rahul Mannan, Xiaoming Wang, Somnath Mahapatra, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 27, 2024
Biomarker Expression and Clinical Outcomes in International Study of Chemoradiation and Magnetic Resonance Imaging-Based Image-Guided Brachytherapy for Locally Advanced Cervical Cancer: BIOEMBRACE
Supriya Chopra, Tjalling Bosse, Nanda Horeweg, et al.
Histopathology
|
May 21, 2022
WHO 2022 landscape of papillary and chromophobe renal cell carcinoma
João Lobo, Riuko Ohashi, Mahul B Amin, et al.
Page
of 21